Kell and XK immunohistochemistry in McLeod myopathy
- PMID: 11562915
- DOI: 10.1002/mus.1154
Kell and XK immunohistochemistry in McLeod myopathy
Abstract
The McLeod syndrome is an X-linked neuroacanthocytosis manifesting with myopathy and progressive chorea. It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK forms a functional complex with the Kell glycoprotein. Here, we present an immunohistochemical study in skeletal muscle of normal controls and a McLeod patient with a XK gene point mutation (C977T) using affinity-purified antibodies against XK and Kell proteins. Histological examination of the affected muscle revealed the typical pattern of McLeod myopathy including type 2 fiber atrophy. In control muscles, Kell immunohistochemistry stained sarcoplasmic membranes. XK immunohistochemistry resulted in a type 2 fiber-specific intracellular staining that was most probably confined to the sarcoplasmic reticulum. In contrast, there was only a weak background signal without a specific staining pattern for XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK protein represents a crucial factor for the maintenance of normal muscle structure and function.
Copyright 2001 John Wiley & Sons, Inc.
Similar articles
-
McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.Transfusion. 2003 Jul;43(7):928-38. doi: 10.1046/j.1537-2995.2003.t01-1-00434.x. Transfusion. 2003. PMID: 12823753
-
Kell, Kx and the McLeod syndrome.Baillieres Best Pract Res Clin Haematol. 1999 Dec;12(4):621-35. doi: 10.1053/beha.1999.0045. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 10895256 Review.
-
Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.Cell. 1994 Jun 17;77(6):869-80. doi: 10.1016/0092-8674(94)90136-8. Cell. 1994. PMID: 8004674
-
The Kell blood group system: Kell and XK membrane proteins.Semin Hematol. 2000 Apr;37(2):113-21. doi: 10.1016/s0037-1963(00)90036-2. Semin Hematol. 2000. PMID: 10791880 Review.
-
Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome.Am J Pathol. 2014 Mar;184(3):800-7. doi: 10.1016/j.ajpath.2013.11.013. Epub 2014 Jan 7. Am J Pathol. 2014. PMID: 24405768 Free PMC article.
Cited by
-
Clinical and molecular research of neuroacanthocytosis.Neural Regen Res. 2013 Mar 25;8(9):833-42. doi: 10.3969/j.issn.1673-5374.2013.09.008. Neural Regen Res. 2013. PMID: 25206731 Free PMC article.
-
Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.J Mov Disord. 2015 May;8(2):41-54. doi: 10.14802/jmd.15009. Epub 2015 May 31. J Mov Disord. 2015. PMID: 26090076 Free PMC article. Review.
-
Movement disorders and neuropathies: overlaps and mimics in clinical practice.J Neurol. 2022 Sep;269(9):4646-4662. doi: 10.1007/s00415-022-11200-0. Epub 2022 Jun 3. J Neurol. 2022. PMID: 35657406 Review.
-
Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis.Blood Cells Mol Dis. 2013 Feb;50(2):80-5. doi: 10.1016/j.bcmd.2012.10.002. Epub 2012 Oct 31. Blood Cells Mol Dis. 2013. PMID: 23122227 Free PMC article.
-
Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea-Acanthocytosis.Mol Genet Genomic Med. 2024 Sep;12(9):e70015. doi: 10.1002/mgg3.70015. Mol Genet Genomic Med. 2024. PMID: 39324427 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
